SCHEMBL21652802

SCHEMBL21652802

Cc1cc(F)cc(C)c1Oc1ccc(N)cc1-c1cn(C)c(=O)c2[nH]ccc12

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15069351 0.91 BRD4 (0.70) BRD4
SCHEMBL23437183 0.87 BRD4 (0.67) BRD4
SCHEMBL22604810 0.86 BRD4 (0.56) BRD4
SCHEMBL15069650 0.86 BRD4 (0.81) BRD4
SCHEMBL15069293 0.85 BRD4 (0.76) BRD4
SCHEMBL21904993 0.84 BRD4 (0.64) BRD4
SCHEMBL21652747 0.83 BRD4 (0.68) BRD4
SCHEMBL15771094 0.83 BRD4 (0.71) BRD4
SCHEMBL21652801 0.83 BRD4 (0.61) BRD4
SCHEMBL22588381 0.82 BRD4 (0.52) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020020288-A1 SULFOXIMINE COMPOUND AS BROMODOMAIN PROTEIN INHIBITOR AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 正大天晴药业集团股份有限公司 2020-01-30 WO disclosed